-
This Treatment Improves Lung Function in CF, Interim Data Shows
A single dose of Translate Bio’s first-in-class mRNA therapy MRT5005 may improve lung function in cystic fibrosis, interim Phase 1/2 trial data shows. Click here to read more about it.
What are your thoughts about this study and its findings?
Sorry, there were no replies found.
Log in to reply.